Navigation Links
Reportlinker Adds The Global Orthobiologics Market - Players, products and technologies driving change 2008
Date:8/31/2010

, and of particular interest, is the rather surprising entry into the segment of negative-pressure woundcare company, Kinetic Concepts, with its proposed acquisition of LifeCell, a leading provider of biological products for soft tissue repair, for US$1.7 billion.

The emergence of gene therapy?

Gene therapy has the potential to provide the ideal solution for treating a variety of musculoskeletal disorders. The promise of gene therapy is the ability to efficiently transfer new genetic material into patient cells to either replace defective genes or introduce therapeutic genes in order to treat disease.

To date, much of the research in gene therapy for the enhancement of spine fusion has centred on the transfer of genes-encoding BMPs and related proteins. Recombinant, osteogenic growth factors are now available to enhance bone repair, particularly in those applications related to the treatment of fracture non-unions and the enhancement of fusion of the spine. However, there is concern that a single dose of an exogenous protein will not induce an adequate osteogenic signal in many patients, particularly in those cases where there is a compromise of host bone and the surrounding soft tissue.

Questions answered

What will the value of stem cell therapies be in 2012?

What are the market growth drivers for the allograft tissue market?

What are the advantages and disadvantages of platelet-derived growth factors?

The synthetic bone graft market was estimated to be worth US$250 million in 2007. By what annual rate is it expected to grow over the next 5 years?

Who are the companies with novel technology in the soft tissue repair area?

What is DePuy's product line-up in the orthobiologics sector?

What is Genzyme's interest in China?

With which Australian company did Smith & Nephew sign a distribution deal in March 2008?

To understand the market and the leading companies that are dri
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Reportlinker Adds All Change in the Coronary Stent Market
2. Reportlinker Adds Urological Disorders Therapeutics to 2016 - Increasing Awareness and Aging Population will Drive the Benign Prostatic Hyperplasia and Urinary Incontinence Markets
3. Reportlinker Adds Diagnostic Imaging Market to 2016 - Nuclear Imaging Systems and Ultrasound Systems to be the Key Revenue Generators
4. Reportlinker Adds Hip and Knee Implants - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
5. Reportlinker Adds Neurostimulation Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
6. Reportlinker Adds The Market for Medical Devices in Brazil, Russia, India & China
7. Reportlinker Adds Pharmaceutical Contract Sales Organizations (CSO) - Emerging Markets to Drive Growth but Talent Acquisition in Specialty Secondary Care Remains a Challenge
8. Reportlinker Adds The Market for Pharmaceuticals in Brazil, Russia, India & China
9. Reportlinker Adds Erectile Dysfunction - Pipeline Assessment and Market Forecasts to 2017
10. Reportlinker Adds Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market Forecasts to 2017
11. Reportlinker Adds Insulin Pumps - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Resources Group finds that the market for colorectal cancer (CRC) ... in the United States , ... Italy , Spain , the ... . The biosimilar erosion of Roche/Genentech/Chugai,s Avastin and Bristol-Myers Squibb/Eli ... of Eli Lilly,s Cyramza, Taiho Pharmaceutical,s Lonsurf, Alchemia,s HA-irinotecan and ...
(Date:8/28/2014)... YORK , Aug. 28, 2014 Levi ... been commenced in the United States District Court for ... behalf of investors who purchased Galectin Therapeutics Inc. ("Galectin" ... 2014 and July 28, 2014. For more ... complaint alleges that during the Class Period the Company ...
(Date:8/28/2014)... , Aug. 28, 2014 Nonin Medical, ... leader in noninvasive medical monitoring, today announced that the ... Model 3231 OEM/eHealth finger pulse oximeter for use in ... pulse oximeter plugs into a telemedicine hub or kiosk ... pulse rate in pediatric to adult patients. The Model ...
Breaking Medicine Technology:The Colorectal Cancer Market Will Remain Steady at $7.7 Billion by 2023, With Biosimilar Erosion Of Key Agents Being Balanced Out By the Launch Of Premium-Priced Therapies 2SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2Nonin Medical Announces FDA Clearance of Nonin Model 3231 USB Pulse Oximeter 2
... and Company (NYSE: LLY ) today issued ... and chief executive officer about his meeting today with ... job creation, American innovation and competiveness: "It,s ... and take part in this very important dialogue today ...
... Dec. 15, 2010 Johnson & Johnson (NYSE: ... Worldwide Chairman, Medical Devices & Diagnostics (MD&D) and Sheri ... Chairmen of the Executive Committee and join William C. ... in an expanded Office of the Chairman.  Both appointments ...
Cached Medicine Technology:Lilly Statement Regarding President Obama's Meeting With U.S. Business Leaders 2Johnson & Johnson Announces Executive Appointments: Alex Gorsky, Vice Chairman, Executive Committee Sheri McCoy, Vice Chairman, Executive Committee 2Johnson & Johnson Announces Executive Appointments: Alex Gorsky, Vice Chairman, Executive Committee Sheri McCoy, Vice Chairman, Executive Committee 3
(Date:8/29/2014)... Most dentists work during normal business hours. That ... their day to be able to go see the dentist. ... a few hours during their increasingly busy days. That is ... It is now possible for people to get the preventative ... happening? , North York Dental has realized that it is ...
(Date:8/29/2014)... The Florida Chiropractic Association held its National ... week August 21-24 and Maryland and Virginia chiropractor ... , Dr. Greenstein presented at three different sessions: ... standing room session; (2) A Panelist at the Plenary ... the Way in Injury Prevention and Maximizing Human Performance; ...
(Date:8/29/2014)... Recent reports, backed by the US ... are working longer hours and taking fewer vacations than ... believes that drinking lots of purified water can help, ... their most popular and effective water purification systems to ... 9/2/2014, customers can save up to $125 off all ...
(Date:8/29/2014)... Auckland, NZ (PRWEB) August 29, 2014 ... of Greg Allen to Chief Executive Officer effective from ... Chief Technology Officer for Winscribe. , “During this time ... Winscribe than Greg Allen,” said Matthew Weavers, Winscribe’s Founder ... leader with a wealth of commercial, IT and management ...
(Date:8/28/2014)... Peoria, Illinois (PRWEB) August 29, 2014 ... of feeling tired all the time, twenty percent of ... to interfere with their daily life. Adrenal Fatigue is ... if you have more of the classic symptoms. Tasks ... flairs up over things that previously didn’t cause irritation, ...
Breaking Medicine News(10 mins):Health News:North York Dental Provides Dental Services to Busy Professionals 2Health News:Sport and Spine Rehab’s CEO Presents at the Florida Chiropractic Association National Convention and Expo 2014 2Health News:Relax this Labor Day Weekend with Great Savings on Easy-Install, Do-It-Yourself Drinking and Whole House Water Filters 2Health News:Winscribe Names Greg Allen as CEO 2Health News:Peoria AlignLife Clinics Focus on Community Education 2
... between tests, researchers say , THURSDAY, Oct. 4 (HealthDay ... DNA testing enables earlier detection of lesions that lead ... women could go longer between screenings, say researchers at ... study included more than 17,000 women ages 29 to ...
... Onyx,Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced ... to retire next year.,Renton, 60, will remain chairman of ... the company is initiating a search for a successor. ... to the newly created,position of executive vice president & ...
... Inc.,(Nasdaq: ANSV ) today announced that it ... review the company,s launch and commercialization,plans for Zingo(TM) ... will take place on Friday,October 12, 2007 from ... York City. To,access the live audio broadcast or ...
... the,November 2006 Rand Corp. study, health care provided ... a year nationally and that 68,percent of illegal ... of millions of newcomers, U.S.-born and foreign-born relatives ... to the U.S. population.,They will also consume energy, ...
... ANA, Calif., Oct. 4 More than 35,million children ... the streets in,costume this Halloween. Although hours of planning ... people fail to consider,the importance of security. "Today, most ... in a sealed wrapper and safe to eat," says ...
... ... organizations, ST. PAUL, Minn., Oct. ... announced today it has,achieved URAC Pharmacy Benefit Management (PBM) accreditation. ... practices, promote quality improvement and protect and,empower consumers. Prime began its ...
Cached Medicine News:Health News:Gene-Based Screen Spots Cervical Cancer Earlier 2Health News:Onyx Pharmaceuticals Announces Management Changes 2Health News:Onyx Pharmaceuticals Announces Management Changes 3Health News:Anesiva to Unveil Zingo(TM) Commercialization Plans 2Health News:Message for Activists at Latino National Congreso Convention: Amnesty Will Exacerbate National Problems and Turn the U.S. into Another Mexico 2Health News:Safety Tips for a Fun and Spooky Halloween 2Health News:Prime Therapeutics Announces URAC Accreditation 2
Colorimetric Assay of Antithrombin III Activity by STA© Analyzers. Bovine thrombin ~12NIH units/mL, freeze-dried....
Immuno-turbidimetric assay for Free Protein Sby STA© Analyzers. Suspension of microparticles coated with monoclonal antibodies to Free Protein S....
Colorimetric Assay of Unfractionated and Low Molecular Weight Heparins by STA© Analyzers. Lyophilized, patent-pending chromogenic substate, CBS 52.44 of ~4.2 moles/vial and bovine factor Xa ~1.1...
Substrate Plasma for Factor VII Assay by STA© Analyzers. Freeze-dried human plasma from which factor VII has been removed by selective immuno-adsorption....
Medicine Products: